Global Gene Delivery or Gene Therapy Drug market growth is projected to reach  US$ 15820 million in 2025 to US$ 49400 million in 2031; it is expected to grow at a CAGR of 20.9% from 2025 to 2031.

Global Gene Delivery or Gene Therapy Drug Market Trends and Analysis 2025-31

The global Gene Delivery or Gene Therapy Drug market size is predicted to grow from US$ 15820 million in 2025 to US$ 49400 million in 2031; it is expected to grow at a CAGR of 20.9% from 2025 to 2031. Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery. The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine. LPI (LP Information) newest research report, the Gene Delivery or Gene Therapy Drug Industry Forecast looks at past sales and reviews total world Gene Delivery or Gene Therapy Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Delivery or Gene Therapy Drug sales for 2025 through 2031. With Gene Delivery or Gene Therapy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Delivery or Gene Therapy Drug industry. This Insight Report provides a comprehensive analysis of the global Gene Delivery or Gene Therapy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Delivery or Gene Therapy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Gene Delivery or Gene Therapy Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Delivery or Gene Therapy Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Delivery or Gene Therapy Drug. This report presents a comprehensive overview, market shares, and growth opportunities of Gene Delivery or Gene Therapy Drug market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Viral Gene Delivery System &nbsp;&nbsp;&nbsp; Non-viral Gene Delivery System Segmentation by Application: &nbsp;&nbsp;&nbsp; Neurological Diseases &nbsp;&nbsp;&nbsp; Cancer &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Biogen &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Gilead Sciences &nbsp;&nbsp;&nbsp; Sarepta Therapeutics &nbsp;&nbsp;&nbsp; Alnylam Pharmaceuticals &nbsp;&nbsp;&nbsp; Amgen &nbsp;&nbsp;&nbsp; Spark Therapeutics &nbsp;&nbsp;&nbsp; Akcea Therapeutics &nbsp;&nbsp;&nbsp; Sunway Biotech &nbsp;&nbsp;&nbsp; SIBIONO &nbsp;&nbsp;&nbsp; AnGes &nbsp;&nbsp;&nbsp; Orchard Therapeutics &nbsp;&nbsp;&nbsp; Human Stem Cells Institute

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Gene Delivery or Gene Therapy Drug Market Size (2020-2031) &nbsp;2.1.2 Gene Delivery or Gene Therapy Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Gene Delivery or Gene Therapy Drug by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Gene Delivery or Gene Therapy Drug Segment by Type &nbsp;2.2.1 Viral Gene Delivery System &nbsp;2.2.2 Non-viral Gene Delivery System &nbsp;2.3 Gene Delivery or Gene Therapy Drug Market Size by Type &nbsp;2.3.1 Gene Delivery or Gene Therapy Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Gene Delivery or Gene Therapy Drug Market Size Market Share by Type (2020-2025) &nbsp;2.4 Gene Delivery or Gene Therapy Drug Segment by Application &nbsp;2.4.1 Neurological Diseases &nbsp;2.4.2 Cancer &nbsp;2.4.3 Other &nbsp;2.5 Gene Delivery or Gene Therapy Drug Market Size by Application &nbsp;2.5.1 Gene Delivery or Gene Therapy Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Gene Delivery or Gene Therapy Drug Market Size Market Share by Application (2020-2025) 3 Gene Delivery or Gene Therapy Drug Market Size by Player &nbsp;3.1 Gene Delivery or Gene Therapy Drug Market Size Market Share by Player &nbsp;3.1.1 Global Gene Delivery or Gene Therapy Drug Revenue by Player (2020-2025) &nbsp;3.1.2 Global Gene Delivery or Gene Therapy Drug Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Gene Delivery or Gene Therapy Drug Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Gene Delivery or Gene Therapy Drug by Region &nbsp;4.1 Gene Delivery or Gene Therapy Drug Market Size by Region (2020-2025) &nbsp;4.2 Global Gene Delivery or Gene Therapy Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Gene Delivery or Gene Therapy Drug Market Size Growth (2020-2025) &nbsp;4.4 APAC Gene Delivery or Gene Therapy Drug Market Size Growth (2020-2025) &nbsp;4.5 Europe Gene Delivery or Gene Therapy Drug Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Gene Delivery or Gene Therapy Drug Market Size by Country (2020-2025) &nbsp;5.2 Americas Gene Delivery or Gene Therapy Drug Market Size by Type (2020-2025) &nbsp;5.3 Americas Gene Delivery or Gene Therapy Drug Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Gene Delivery or Gene Therapy Drug Market Size by Region (2020-2025) &nbsp;6.2 APAC Gene Delivery or Gene Therapy Drug Market Size by Type (2020-2025) &nbsp;6.3 APAC Gene Delivery or Gene Therapy Drug Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Gene Delivery or Gene Therapy Drug Market Size by Country (2020-2025) &nbsp;7.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2020-2025) &nbsp;7.3 Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Gene Delivery or Gene Therapy Drug by Region (2020-2025) &nbsp;8.2 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Gene Delivery or Gene Therapy Drug Market Forecast &nbsp;10.1 Global Gene Delivery or Gene Therapy Drug Forecast by Region (2026-2031) &nbsp;10.1.1 Global Gene Delivery or Gene Therapy Drug Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.1.3 APAC Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.1.4 Europe Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.1.5 Middle East & Africa Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.2 Americas Gene Delivery or Gene Therapy Drug Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.2.2 Canada Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.2.3 Mexico Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.2.4 Brazil Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.3 APAC Gene Delivery or Gene Therapy Drug Forecast by Region (2026-2031) &nbsp;10.3.1 China Gene Delivery or Gene Therapy Drug Market Forecast &nbsp;10.3.2 Japan Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.3.3 Korea Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.3.4 Southeast Asia Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.3.5 India Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.3.6 Australia Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.4 Europe Gene Delivery or Gene Therapy Drug Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.4.2 France Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.4.3 UK Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.4.4 Italy Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.4.5 Russia Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.5 Middle East & Africa Gene Delivery or Gene Therapy Drug Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.5.2 South Africa Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.5.3 Israel Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.5.4 Turkey Market Gene Delivery or Gene Therapy Drug Forecast &nbsp;10.6 Global Gene Delivery or Gene Therapy Drug Forecast by Type (2026-2031) &nbsp;10.7 Global Gene Delivery or Gene Therapy Drug Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Gene Delivery or Gene Therapy Drug Forecast 11 Key Players Analysis &nbsp;11.1 Biogen &nbsp;11.1.1 Biogen Company Information &nbsp;11.1.2 Biogen Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.1.3 Biogen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Biogen Main Business Overview &nbsp;11.1.5 Biogen Latest Developments &nbsp;11.2 Novartis &nbsp;11.2.1 Novartis Company Information &nbsp;11.2.2 Novartis Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.2.3 Novartis Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Novartis Main Business Overview &nbsp;11.2.5 Novartis Latest Developments &nbsp;11.3 Gilead Sciences &nbsp;11.3.1 Gilead Sciences Company Information &nbsp;11.3.2 Gilead Sciences Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.3.3 Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Gilead Sciences Main Business Overview &nbsp;11.3.5 Gilead Sciences Latest Developments &nbsp;11.4 Sarepta Therapeutics &nbsp;11.4.1 Sarepta Therapeutics Company Information &nbsp;11.4.2 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.4.3 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Sarepta Therapeutics Main Business Overview &nbsp;11.4.5 Sarepta Therapeutics Latest Developments &nbsp;11.5 Alnylam Pharmaceuticals &nbsp;11.5.1 Alnylam Pharmaceuticals Company Information &nbsp;11.5.2 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.5.3 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Alnylam Pharmaceuticals Main Business Overview &nbsp;11.5.5 Alnylam Pharmaceuticals Latest Developments &nbsp;11.6 Amgen &nbsp;11.6.1 Amgen Company Information &nbsp;11.6.2 Amgen Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.6.3 Amgen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Amgen Main Business Overview &nbsp;11.6.5 Amgen Latest Developments &nbsp;11.7 Spark Therapeutics &nbsp;11.7.1 Spark Therapeutics Company Information &nbsp;11.7.2 Spark Therapeutics Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.7.3 Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Spark Therapeutics Main Business Overview &nbsp;11.7.5 Spark Therapeutics Latest Developments &nbsp;11.8 Akcea Therapeutics &nbsp;11.8.1 Akcea Therapeutics Company Information &nbsp;11.8.2 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.8.3 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Akcea Therapeutics Main Business Overview &nbsp;11.8.5 Akcea Therapeutics Latest Developments &nbsp;11.9 Sunway Biotech &nbsp;11.9.1 Sunway Biotech Company Information &nbsp;11.9.2 Sunway Biotech Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.9.3 Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Sunway Biotech Main Business Overview &nbsp;11.9.5 Sunway Biotech Latest Developments &nbsp;11.10 SIBIONO &nbsp;11.10.1 SIBIONO Company Information &nbsp;11.10.2 SIBIONO Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.10.3 SIBIONO Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 SIBIONO Main Business Overview &nbsp;11.10.5 SIBIONO Latest Developments &nbsp;11.11 AnGes &nbsp;11.11.1 AnGes Company Information &nbsp;11.11.2 AnGes Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.11.3 AnGes Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 AnGes Main Business Overview &nbsp;11.11.5 AnGes Latest Developments &nbsp;11.12 Orchard Therapeutics &nbsp;11.12.1 Orchard Therapeutics Company Information &nbsp;11.12.2 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.12.3 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Orchard Therapeutics Main Business Overview &nbsp;11.12.5 Orchard Therapeutics Latest Developments &nbsp;11.13 Human Stem Cells Institute &nbsp;11.13.1 Human Stem Cells Institute Company Information &nbsp;11.13.2 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Product Offered &nbsp;11.13.3 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Human Stem Cells Institute Main Business Overview &nbsp;11.13.5 Human Stem Cells Institute Latest Developments 12 Research Findings and Conclusion

Report	Global Gene Delivery or Gene Therapy Drug Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI13702

Buyer Information

Order Summary